Your browser doesn't support javascript.
loading
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma.
Kim, Dong Won; Bukhari, Ali; Lutfi, Forat; Zafforoni, Facundo; Merechi, Fikru; Mustafa Ali, Moaath K; Gottlieb, David; Lee, Seung T; Kocoglu, Mehmet H; Hardy, Nancy M; Yared, Jean; Rapoport, Aaron P; Dahiya, Saurabh; Law, Jennie Y.
Afiliación
  • Kim DW; Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
  • Bukhari A; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Lutfi F; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Zafforoni F; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Merechi F; Department of Pathology, University of Maryland Medical Center, Baltimore, MD, USA.
  • Mustafa Ali MK; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Gottlieb D; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Lee ST; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Kocoglu MH; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Hardy NM; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Yared J; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Rapoport AP; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Dahiya S; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Law JY; Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Leuk Lymphoma ; 63(6): 1339-1347, 2022 06.
Article en En | MEDLINE | ID: mdl-35045791
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso / Linfohistiocitosis Hemofagocítica / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso / Linfohistiocitosis Hemofagocítica / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos